These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


268 related items for PubMed ID: 15021047

  • 21. The assessment and management of tinea capitis in children.
    Ali S, Graham TA, Forgie SE.
    Pediatr Emerg Care; 2007 Sep; 23(9):662-5; quiz 666-8. PubMed ID: 17876261
    [Abstract] [Full Text] [Related]

  • 22. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J, Skerlev M, Orofino-Costa R, Zaitz VC, Horvath A, Chouela E, Romero G, Gourmala N, Paul C, Tinea Capitis Study Group.
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [Abstract] [Full Text] [Related]

  • 23. Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis.
    Gupta AK, Drummond-Main C.
    Pediatr Dermatol; 2013 May; 30(1):1-6. PubMed ID: 22994156
    [Abstract] [Full Text] [Related]

  • 24. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST, Cucé LC, Foss NT, Marques SA, Santamaria JR.
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [Abstract] [Full Text] [Related]

  • 25. Microsporum canis tinea capitis in an 8-month-old infant successfully treated with 2 weekly pulses of oral itraconazole.
    Koumantaki E, Georgala S, Rallis E, Papadavid E.
    Pediatr Dermatol; 2001 Sep; 18(1):60-2. PubMed ID: 11207976
    [Abstract] [Full Text] [Related]

  • 26. Treatment of tinea capitis: beyond griseofulvin.
    Elewski BE.
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 2):S27-30. PubMed ID: 10367913
    [Abstract] [Full Text] [Related]

  • 27. [Tinea capitis].
    Fukuda T.
    Med Mycol J; 2011 Jun; 52(1):7-13. PubMed ID: 21441707
    [Abstract] [Full Text] [Related]

  • 28. Management of tinea capitis in Israel: A comparative study.
    Shemer A, Gupta AK, Galili E, Daniel R, Kassem R, Farhi R, Grunwald H, Bamimore MA.
    Pediatr Dermatol; 2021 Jul; 38(4):806-811. PubMed ID: 33998709
    [Abstract] [Full Text] [Related]

  • 29. Microsporum canis infections in children: results of a new oral antifungal therapy.
    Ginter G.
    Mycoses; 1996 Jul; 39(7-8):265-9. PubMed ID: 9009643
    [Abstract] [Full Text] [Related]

  • 30. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
    Fleece D, Gaughan JP, Aronoff SC.
    Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
    [Abstract] [Full Text] [Related]

  • 31. Tinea in Tots: Cases and Literature Review of Oral Antifungal Treatment of Tinea Capitis in Children under 2 Years of Age.
    Zampella JG, Kwatra SG, Blanck J, Cohen B.
    J Pediatr; 2017 Apr; 183():12-18.e3. PubMed ID: 28088394
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tinea capitis: epidemiology, diagnosis and management strategies.
    Pomeranz AJ, Sabnis SS.
    Paediatr Drugs; 2002 Apr; 4(12):779-83. PubMed ID: 12431130
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
    Dastghaib L, Azizzadeh M, Jafari P.
    J Dermatolog Treat; 2005 Feb; 16(1):43-6. PubMed ID: 15897167
    [Abstract] [Full Text] [Related]

  • 35. Tinea capitis update: a continuing conflict with an old adversary.
    Chen BK, Friedlander SF.
    Curr Opin Pediatr; 2001 Aug; 13(4):331-5. PubMed ID: 11717558
    [Abstract] [Full Text] [Related]

  • 36. Tinea capitis: fluconazole in Trichophyton tonsurans infection.
    Mercurio MG, Silverman RA, Elewski BE.
    Pediatr Dermatol; 1998 Aug; 15(3):229-32. PubMed ID: 9655323
    [Abstract] [Full Text] [Related]

  • 37. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M, Monod M, Baudraz-Rosselet F, Panizzon RG.
    Dermatology; 1998 Aug; 197(4):361-7. PubMed ID: 9873175
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.